Hosted by Drug Discovery World and sponsored by Oxford Nanopore Technologies, this webinar explores developments in CGT drug discovery and development.
 
You will hear from Brian Culley, CEO of Lineage Cell Therapeutics, Will Decker, CSO of Diakonos Oncology, and John Maher, Scientific Founder and CSO of Leucid Bio. In addition, you will see a sponsor introduction from Oxford Nanopore, showcasing how its sequencing technology provides a comprehensive, single-platform solution to help overcome key challenges in cell and gene therapy.
 
You will learn:

• What challenges the CGT drug discovery and development sector face and how they can be overcome
• Where the global opportunity lies for advanced therapies and how they can be maximised
• How technology can help expedite the CGT drug discovery process
• How you can identify bottlenecks in advanced therapeutic delivery and what to do about them
   
  A Q&A with the speakers follows the presentations.